MERAIODE: A Phase II Redifferentiation Trial with Trametinib and <sup>131</sup> I in Metastatic Radioactive Iodine Refractory <i>RAS</i> Mutated Differentiated Thyroid Cancer
Sophie Leboulleux, D. Benisvy, David Taïeb, Marie Attard, Claire Bournaud, Marie Terroir-Cassou-Mounat, Ludovic Lacroix, Nadège Anizan, Aurélie Schiazza, Marie Eve Garcia, Abir Al Ghuzlan, Livia Lamartina, Martin Schlumberger, Yann Godbert, Isabelle Borget
Abstract
International audience
Topics & Concepts
MedicineThyroid cancerInternal medicineOncologyThyroidThyroid Cancer Diagnosis and TreatmentCancer-related Molecular PathwaysAdrenal and Paraganglionic Tumors